Pharma Journalist -

The U.S. Food and Drug Administration approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.…
Read More...

Samsung BioLogics and GI Innovation signed a Contract Development Organization (CDO) contract for immunochemotherapy at Samsung BioLogics headquarters on Thursday. GI Innovation…
Read More...

Sartorius Stedim Biotech (SSB) is introducing its new generation of ambr 15 cell culture automated microbioreactor system. The Generation 2 is the successor to the well-established ambr…
Read More...

AMAL Therapeutics (AMAL), a Swiss biotech developing novel, peptide-based therapeutic cancer vaccines, announces that it has entered into a collaborative agreement with Boehringer…
Read More...

Amgen and Syapse announced a precision medicine collaboration in oncology. Under the terms of the agreement, Amgen and Syapse will develop observational research analytics to assess…
Read More...

Takeda Pharmaceutical Company Limited announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year presence in San Diego, the…
Read More...

Abbott announced that m-PIMA HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). The…
Read More...

Glenmark Therapeutics Inc., USA, a wholly-owned subsidiary of Glenmark Holding SA., announced a co-promotion agreement with Otonomy, a biopharmaceutical company dedicated to the…
Read More...

Exelixis, Inc. announced that it is initiating COSMIC-313, a phase 3 pivotal trial of cabozantinib (CABOMETYX) in combination with nivolumab (Opdivo) and ipilimumab (Yervoy) versus…
Read More...

The U.S. Food and Drug Administration announced the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3…
Read More...